Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies

Blood

Volumn 98, Issue 8, 2001, Pages 2332-2338

  Sanz, Guillermo F ^a,b   Saavedra, Silvana ^a,b   Flanelles, Dolores ^a,b   Senent, Leonor ^a,b   Cervera, Jose ^a,b   Barragán, Eva ^a,b   Jiménez, Carmen ^a,b   Larrea, Luis ^a,b   Martín, Guillermo ^a,b   Martínez, Jesús ^a,b   Jarque, Isidro ^a,b   Moscardó, Federico ^a,b   Plumé, Gemma ^a,b   Andreu, Rafael ^a,b   Regadera, Ana I ^a,b   García, Inmaculada ^a,b   Mollá, Susana ^a,b   Solves, Pilar ^a,b   De La Rubia, Javier ^a,b   Bolufer, Pascual ^a,b   Benlloch, Luis ^a,b   Soler, María A ^a,b   Marty, María L ^a,b   Sanz, Miguel A ^a,b   more..

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Centro de Transfusion de la Comunidad Valenciana   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CHLORPHENIRAMINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; LYMPHOGLOBULINE; METHYLPREDNISOLONE; PARACETAMOL; PREDNISONE; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE DISEASE; ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CANCER SURVIVAL; CHRONIC DISEASE; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; LEUKOCYTE COUNT; MALE; MALIGNANT NEOPLASTIC DISEASE; NEUTROPHIL; PRIORITY JOURNAL; PROPHYLAXIS; STANDARDIZATION; THROMBOCYTE COUNT; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

EID: 0035889124     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.8.2332     Document Type: Article

References (50)

1. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med. 1997;337:373-381.
2. Rubinstein P, Carrier C, Scaradavou M, et al. Outcome among 562 recipients of placental blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577.
3. Rocha V, Arcese W, Sanz G, et al. Prognostic factors of outcome after unrelated cord blood transplant (UCBT) in adults with hematologic malignancies [abstract]. Blood. 2000;96:587a.
4. Laughlin MJ, Barker J, Bambach B, et al. Hematopoiefic engraftment and survival after unrelated donor umbilical cord blood (UCB) transplantation in adult recipients [abstract]. Blood. 2000;96:587a.
5. Kurtzberg J, Laughlin MJ, Smith CA, et al. Hematopoietic recovery in adult recipients following unrelated umbilical cord blood transplantation [abstract]. Blood. 1997;90:480a.
6. Long G, Madan B, Kurtzberg J, et al. Unrelated umbilical cord blood transplants in adult patients (PTS) with hematological malignancies or genetic disorders [abstract]. Blood. 1999;94:570a.
7. Laporte JP, Lesage S, Portnoi MF, et al. Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience. Bone Marrow Transplant. 1998;22(suppl 1):S76-S77.
8. Goldberg SL, Chedid S, Jennis AA, et al. Unrelated cord blood transplantation in adults: a single institution experience [abstract]. Blood. 2000;96:208a.
9. Sanz GF, Saavedra S, Jimenez C, et al. Unrelated donor cord-blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution. Bone Marrow Transplant. 2001:27:693-701.
10. Laporte JR Gorin NC, Rubinstein P, et al. Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia. N Engl J Med. 1996;335:167-170.
11. Lambertenghi Deliliers G, Soligo D, Delia Volpe A, et al. Unrelated mismatched cord blood transplantation in an adult with secondary AML. Bone Marrow Transplant. 1996;18:469-472.
12. Gonzalez Barca E, Querol S, Grañena A, et al. Umbilical cord blood transplantation from an unrelated donor in an adult weighing 90 kilograms: role of immunosuppression in engraftment. Bone Marrow Transplant. 1997;20:333-336.
13. Laughlin MJ, Rizzieri DA, Smith CA, et al. Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia. Leuk Res. 1998;22:215-219.
14. Gian VG, Moreb JS, AbdeI-Mageed A, et al. Successful salvage using mismatched umbilical cord blood transplant in an adult with recurrent acute myelogenous leukemia failing autologous peripheral blood progenitor cell transplant: a case history and review. Bone Marrow Transplant. 1998; 21:1197-1200.
15. Pecora AL, Stiff P, Jennis A, et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood. Bone Marrow Transplant. 2000;25:797-799.
16. Goldberg SL, Pecora AL, Rosenbluth RJ, Jennis AA, Preti RA. Treatment of leukemic relapse following unrelated umbilical cord blood transplantation with interleukin-2: potential for augmenting graft-versus-leukemia and graft-versus-host with cytokines. Bone Marrow Transplant. 2000;26:353-355.
17. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. Blood. 1997; 90:4665-4678.
18. Terasaki PI, McLelland J. Microdroplet assay of human serum cytoxins. Nature. 1964;204:988-1000.
19. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serologic DR typing in clinical practice including donorrecipient matching in cadaveric transplantation. Tissue Antigens. 1992;39:225-235.
20. Buyse I, Decorte R, Cuppens H, et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens. 1993;41:1-14.
21. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A. 1995;92:10119-10122.
22. McNiece I, Kern B, Zilm K, Brunaud C, Dziem G, Briddell R. Minimization of CD34+ cell enumeration variability using the ProCOUNT standardized methodology. J Hematother. 1998;7:499-504.
23. Mossuz P, Dobo I, Geneway MC, et al. Use of collagen for standardization of PBSC graft quality evaluation: a multicenter comparative analysis of commercial collagen-based and methylcellulose-based colony-forming unit (CFU) assay kits. J Hematother. 1998;7:351-359.
24. Boerwinkle E, Xiong W, Fourest E, Chan L.. Rapid typing of tandemly repeated hypervariable loci by the porymerase chain reaction: application to the apolipoprotein B 3' hypervariable region. Proc Natl Acad Sci U S A. 1989;86:212-216.
25. Budowle B, Chakraborty R, Giusti AM, et al, Analysis of the VNTR locus D1 S80 by PCR followed by high resolution PAGE. Am J Hum Genet. 1991; 48:137-144.
26. Richards B, Heilig R, Oberle I, Storjohann L, Horn GT. Rapid PCR analysis of the St14 (DXS52) VNTR. Nucleic Acids Res. 1991;19:1944.
27. Najfeld V, Burnett W, Vlachos A, Scigliano E, Isola L, Fruchtman S. Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes. Bone Marrow Transplant. 1997;19:829-834.
28. Cross NC, Hughes TP, Feng L, et al. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: correlations with acute graftversus-host disease and relapse. Br J Haematol. 1993;84:67-74.
29. Cross NC, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia. 1994;9:186-189.
30. Sinclair PB, Green AR, Grace C, Nacheva EP. Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridization system. Blood. 1997;90:1395-1402.
31. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of HLA-matched sibling donors. Transplantation. 1974;18:295-304.
32. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825-828.
33. Shulman HM, Sullivan KM, Weiden PI, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
34. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
35. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
36. Dixon WJ. BMDP Statistical Software. Berkeley, CA: University of California Press; 1990.
37. Greenberg P, Cox C, LeBeau M, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079-2088.
38. Locatelli F, Rocha V, Ertem M, et al. Influence of preparative regimen and methotrexate for GVHD prophylaxis on engraftment after related cord blood transplant for patients with hemogobinopathies [abstract]. Blood. 2000;96:200a.
39. Rocha V, Cornish J, Sievers E, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001;97:2962-2971.
40. Atkinson K, Horowitz MM, Biggs JC, et al. The clinical diagnosis of acute graft-versus-host disease: a diversity of views amongst marrow transplant centers. Bone Marrow Transplant. 1988;3:5-10.
41. Rowlings PA, Przepiorka D, Klein JP, et al. IB-MTR Severity Index for grading acute graft-versus-host disease: a retrospective comparison with Glucksberg grade. Br J Haematol. 1997;97:855-864.
42. Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med. 1998;338:962-968.
43. McGlave PB, Shu XO, Wen W, et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the National Marrow Donor Program. Blood. 2000;95:2219-2225.
44. Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Ann Intern Med. 1988;108:806-814.
45. Sullivan KM, Weiden PL, Storb R, et al, Influence of acute and chronic graft-versus-host disease in relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment for acute and chronic leukemia. Blood. 1989;73:1720-1728.
46. Rocha V, Wagner JE, Sobocinski KA, et al, Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000;342:1846-1854.
47. Barker JN, Davies SM, De For T, Ramsay NKC, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow. Blood. 2001;97:2957-2961.
48. Migliaccio AR, Adamson JW, Stevens CE, et al. Cell dose and speed of engraftment in placental/ umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood., 2000;96:2717-2722.
49. Locatelli F, Rocha V, Chastang O, et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord Cord Blood Transplant Group. Blood. 1999; 93:3662-3671.
50. Gluckman E, Rocha V, Gamier F, et al. Analysis of factors associated with engraftment after umbilical cord blood transplantation (UCBT) [abstract]. Blood. 2000;96:588a.